Price list analysis of targeted drug lorlatinib/lorlatinib in 2025

Lorlatinib/lorlatinib(Lorlatinib), as a new generation of oral tyrosine kinase inhibitors, is specifically targeted at patients with ALK and ROS1 fusion protein-positive non-small cell lung cancer. It has become increasingly popular around the world in recent years. As its clinical efficacy continues to be recognized, the price of lorlatinib has also become a focus of concern for patients and the medical industry. The original drug of lorlatinib in the Chinese market is named lorlatinib tablets and has been included in the national Class B medical insurance reimbursement system, which provides patients with certain financial burden relief. Its common packaging specifications include 90 tablets of 25mg and 30 tablets of 100mg. The overall market price is about 20,000 yuan. This price positioning reflects its market value as a high-end targeted drug, and also illustrates the high production cost and R&D investment of the drug.

In comparison, the price of the original drug lorlatinib in the Hong Kong market is significantly higher, usually between RMB 30,000 and RMB 50,000. The formation of price differences is due to the medical policies and tax structures of different regions on the one hand, and is closely related to procurement channels and market demand on the other. In addition, the price of original drugs in the Turkish market is relatively low, roughly around 10,000 yuan, showing the diversified pricing strategies of imported drugs in different countries and regions.

Against the backdrop of high prices for original drugs, the emergence of generic drugs has made lorlatinib treatment more economically feasible. Although generic drugs do not completely replace the original drugs, their active ingredients are basically the same as the original drugs, which can provide patients with more economical medication options. For example, a generic drug of lorlatinib produced by a pharmaceutical factory in Laos has a specification of 100mg*30 tablets and sells for only about 1,000 yuan. Prices will fluctuate due to exchange rate fluctuations and market supply, but overall, generic drugs significantly reduce patients' medication costs.

References：https://www.lorbrena.com/